Modeling-Based Response-Guided Glecaprevir-Pibrentasvir Therapy for Chronic Hepatitis C to Identify Patients for Ultrashort Treatment Duration

We recently showed in a proof-of-concept study that real-time modeling-based response-guided therapy can shorten hepatitis C virus treatment duration with sofosbuvir-velpatasvir, elbasvir-grazoprevir, and sofosbuvir-ledipasvir without compromising efficacy, confirming our retrospective modeling repo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Autores principales: Dasgupta, Swikriti, Imamura, Michio, Gorstein, Evan, Nakahara, Takashi, Tsuge, Masataka, Churkin, Alexander, Yardeni, David, Etzion, Ohad, Uprichard, Susan L, Barash, Danny, Cotler, Scott J, Dahari, Harel, Chayama, Kazuaki
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Major Articles and Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768761/
https://ncbi.nlm.nih.gov/pubmed/32363394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa219
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares